Abigail G. Matthews

Comparative effectiveness of extended-release naltrexone versus buprenorphine-naloxone for opioid relapse prevention (X:BOT): a multicentre, open-label, randomised controlled trial

Joshua D. Lee, Edward V. Nunes, Patricia Novo et al. · The Lancet · 2017 · 681 citations · Full text

Opioid Epidemic, Comparative Effectiveness, Substance Abuse +10

Internet-Delivered Treatment for Substance Abuse: A Multisite Randomized Controlled Trial

Aimee Campbell, Edward V. Nunes, Abigail G. Matthews et al. · American Journal of Psychiatry · 2014 · 260 citations · Full text

Long‐term outcomes after randomization to buprenorphine/naloxone versus methadone in a multi‐site trial

Yih‐Ing Hser, Elizabeth Evans, David Huang et al. · Addiction · 2015 · 208 citations · Full text

A randomized placebo-controlled trial of N-acetylcysteine for cannabis use disorder in adults

Kevin M. Gray, Susan C. Sonne, Erin A. McClure et al. · Drug and Alcohol Dependence · 2017 · 149 citations · Full text

Cannabis Use, Substance Abuse, Substance Use +12

Prevalence and treatment of opioid use disorders among primary care patients in six health systems

Gwen T. Lapham, Denise M. Boudreau, Eric A. Johnson et al. · Drug and Alcohol Dependence · 2019 · 90 citations · Full text

Opioid Epidemic, Substance Use, Primary Care Patients +16